Quibim provides end-to-end solutions from the creation of highly accurate AI models to their deployment and implementation in sites.
Accelerating the arrival
of precision medicine
We develop novel imaging biomarker panels to deeply analyze disease mechanisms, maximize drug programs, and monitor treatment efficacy using a whole-body and tissue-agnostic approach for every patient.
Value-based strategic partnerships
with biopharma companies
Development & validation
of AI algorithms
Including radiomics, deep features and deep learning techniques.
By optimizing clinical study design using our AI-based models.
AI & Radiomics
To deploy our solutions as digital biomarkers and companion diagnostics (CDx) in real-world scenarios.
To advance the development of AI-based models that detect pathologies early and predict outcomes.
Mastering the harmonization of real-world data (RWD)
Correcting variabilities in image quality across sites and scanners, and developing generalizable predictive models from retrospective observational studies.
Prediction of treatment response with a biopharma partner
Want to collaborate with us?
Leave your details and let’s build the future of healthcare together